FDS
LLY icon

First Dallas Securities’s Eli Lilly LLY Stock Holding History

First Dallas Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.96M Sell
5,392
-361
-6% -$366K 1.83% 11
2025
Q4 		$6.18M Sell
5,753
-190
-3% -$182K 2.3% 9
2025
Q3 		$4.53M Buy
5,943
+1,500
+34% +$1.12M 1.7% 13
2025
Q2 		$3.46M Buy
4,443
+5
+0.1% +$3.88K 1.37% 17
2025
Q1 		$3.67M Buy
4,438
+426
+11% +$354K 1.53% 13
2024
Q4 		$3.1M Buy
4,012
+100
+3% +$82.8K 1.26% 22
2024
Q3 		$3.47M Sell
3,912
-191
-5% -$172K 1.45% 18
2024
Q2 		$3.72M Sell
4,103
-100
-2% -$80K 1.63% 12
2024
Q1 		$3.27M Sell
4,203
-20
-0.5% -$14.2K 1.5% 17
2023
Q4 		$2.46M Buy
+4,223
New +$2.46M 1.27% 21
2023
Q3 		– Sell
-4,625
Closed -$2.17M – 163
2023
Q2 		$2.17M Hold
4,625
– – 1.21% 25
2023
Q1 		$1.59M Buy
4,625
+2
+0% +$675 0.94% 31
2022
Q4 		$1.69M Buy
4,623
+500
+12% +$177K 1.02% 28
2022
Q3 		$1.33M Buy
4,123
+576
+16% +$182K 0.92% 25
2022
Q2 		$1.15M Sell
3,547
-1,074
-23% -$322K 0.78% 40
2022
Q1 		$1.32M Buy
4,621
+21
+0.5% +$5.41K 0.75% 39
2021
Q4 		$1.27M Hold
4,600
– – 0.83% 38
2021
Q3 		$1.06M Buy
4,600
+1
+0% +$247 0.73% 43
2021
Q2 		$1.06M Buy
4,599
+301
+7% +$60.5K 0.69% 45
2021
Q1 		$803K Buy
+4,298
New +$841K 0.68% 47
2018
Q1 		– Sell
-1,993
Closed -$168K – 120
2017
Q4 		$168K Sell
1,993
-499
-20% -$42.5K 0.11% 108
2017
Q3 		$213K Buy
2,492
+2
+0.1% +$164 0.15% 100
2017
Q2 		$205K Sell
2,490
-1,649
-40% -$135K 0.15% 102
2017
Q1 		$348K Sell
4,139
-199
-5% -$15.9K 0.24% 77
2016
Q4 		$319K Sell
4,338
-288
-6% -$21.4K 0.22% 79
2016
Q3 		$371K Buy
+4,626
New +$370K 0.28% 72

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Dallas Securities's LLY Position: Q1 2026 in Review

First Dallas Securities reduced its Eli Lilly (LLY) stake by 6.3% in Q1 2026, selling an estimated $366K and leaving 5,392 shares worth $4.96M. The position accounts for 1.83% of the portfolio, ranked #11.

First Dallas Securities first reported a position in LLY in Q3 2016 and has held it in 26 quarters since. The position peaked at $6.18M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Dallas Securities held 5,392 shares of Eli Lilly worth $4.96M as of Q1 2026.
  • First Dallas Securities sold 361 Eli Lilly shares in Q1 2026, an estimated $366K.
  • Eli Lilly made up 1.83% of First Dallas Securities's portfolio in Q1 2026, its #11 holding.
  • First Dallas Securities first reported a position in Eli Lilly in Q3 2016 and has held it in 26 quarters since.
  • First Dallas Securities's Eli Lilly position peaked at $6.18M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Dallas Securities's 13F filing for Q1 2026, filed 27 Apr 2026.